✦ LIBER ✦

Long-term efficacy of angiotensin-converting-enzyme inhibition with captopril in mild-to-moderate essential hypertension.

✍ Scribed by KO Stumpe; A Overlack; R Kolloch; S Schreyer

Book ID: 117942991
Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 844 KB
Volume: 14
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.1982.tb02068.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolic effects of long-term angiotens

Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition

✍ R. Reneland; P.-E. Andersson; A. Haenni; H. Lithell 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 566 KB

Fifty patients with mild to moderate essential hypertension were randomized to receive either 20 mg fosinopril daily for 16 weeks or placebo for 4 weeks followed by 12 weeks of 50 mg atenolol daily. Prior to these 16 weeks there was a placebo wash-out period of 2-6 weeks. Blood pressure measurements

Long-term renal preservation in essentia

Long-term renal preservation in essential hypertension: Angiotensin converting enzyme inhibition is superior to β-blockade

✍ Anders Himmelmann; Lennart Hansson; Bengt-Göran Hansson; Hans Hedstrand; Kay Sko 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 290 KB

Dose-response relation of the angiotensi

Dose-response relation of the angiotensin converting enzyme inhibitor ramipril in mild to moderate essential hypertension

✍ Udo Walter; Ronald Forthofer; Peter Uwe Witte 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 823 KB

Cardiovascular effects and regional bloo

Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertension

✍ Hector O. Ventura; Edward D. Frohlich; Franz H. Messerli; Isaac Kobrin; Merrill 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 497 KB

The effects of benazepril, a new angiote

The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: A multicenter study

✍ Moser, M; Abraham, P A; Bennett, W M; Brachfeld, N; Goodman, R P; McKenney, J M; 📂 Article 📅 1991 🏛 Nature Publishing Group 🌐 English ⚖ 557 KB

Converting Enzyme Inhibition in Mild and

Converting Enzyme Inhibition in Mild and Moderate Essential Hypertension: I. Acute Effects on Blood Pressure, the Renin-Angiotensin System and Blood Bradykinin after a Single Dose of Captopril

✍ RASMUSSEN, STEN ;LETH, ARNE ;IBSEN, HANS ;NIELSEN, META DAMKJAER ;NIELSEN, FINN 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 540 KB